CrowdStrike Unveils 4-for-1 Stock Split After More Than 20x Share Surge Since IPO

Technology

Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities

Life Science

Alphabet’s Growth Thesis Reshaped by Anthropic’s Looming IPO via TPU Supply and Equity Stakes

Technology

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Life Science

Broadcom’s AI Revenue Surges 143% in Q2, Yet Shares Tumble Post-Earnings

Technology

USAR Secures $1.6B CHIPS Funding and $1.2B Factory, With Huge Risks Remaining

Mining

SpaceX IPO Set for June 12, Red Flags Cast Doubt on $1.75T Valuation

Technology

Three AI Healthcare Stocks Chart Distinct Growth Trajectories

Life Science, Technology

Berkshire Pours $10B Into Alphabet, Which Outperforms Nvidia This Year

Technology

Nuclear Stocks: Sharp Hype vs. Fundamentals Divide in AI Boom

Energy, Technology

IBM Surges 9.1% to Fresh All-Time High; Barclays Flags Over 50% Potential Upside

Technology

How Long Can Micron Keep Rallying? June 24 Earnings Is the Key Focus

Technology

Can Jensen Huang’s COMPUTEX 2026 Spark Another Nvidia Stock Rally?

Technology

From Chips to Servers to Software: 3 Stocks Fueling AI’s Next Leg Higher

Technology

5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors

Life Science